|
1
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: a role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hugo H, Ackland ML, Blick T, Lawrence MG,
Clements JA, Williams ED and Thompson EW: Epithelial-mesenchymal
and mesenchymal-epithelial transitions in carcinoma progression. J
Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: an emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bronner C: Control of DNMT1 abundance in
epigenetic inheritance by acetylation, ubiquitylation, and the
histone code. Sci Signal. 4:pe32011.PubMed/NCBI
|
|
10
|
Hashimoto H, Vertino PM and Cheng X:
Molecular coupling of DNA methylation and histone methylation.
Epigenomics. 2:657–669. 2010. View Article : Google Scholar
|
|
11
|
Du Z, Song J, Wang Y, et al: DNMT1
stability is regulated by proteins coordinating deubiquitination
and acetylation-driven ubiquitination. Sci Signal.
3:ra802010.PubMed/NCBI
|
|
12
|
Hong Q and Shao ZM:
Ubiquitination/deubiquitination and acetylation/deacetylation:
making DNMT1 stability more coordinated. Acta Pharmacol Sin.
32:139–140. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bronner C, Krifa M and Mousli M:
Increasing role of UHRF1 in the reading and inheritance of the
epigenetic code as well as in tumorogenesis. Biochem Pharmacol.
86:1643–1649. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pacaud R, Brocard E, Lalier L, Hervouet E,
Vallette FM and Cartron PF: The DNMT1/PCNA/UHRF1 disruption induces
tumorigenesis characterized by similar genetic and epigenetic
signatures. Sci Rep. 4:42302014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hervouet E, Lalier L, Debien E, et al:
Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis
from human and mice glial cells. PLoS One. 5:e113332010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Scheel C and Weinberg RA: Cancer stem
cells and epithelial-mesenchymal transition: concepts and molecular
links. Semin Cancer Biol. 22:396–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Morel AP, Lievre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jung MJ, Rho JK, Kim YM, et al:
Upregulation of CXCR4 is functionally crucial for maintenance of
stemness in drug-resistant non-small cell lung cancer cells.
Oncogene. 32:209–221. 2013. View Article : Google Scholar
|
|
20
|
Korkaya H, Kim GI, Davis A, et al:
Activation of an IL6 inflammatory loop mediates trastuzumab
resistance in HER2+ breast cancer by expanding the
cancer stem cell population. Mol Cell. 47:570–584. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sukowati CH, Rosso N, Croce LS and
Tiribelli C: Hepatic cancer stem cells and drug resistance:
relevance in targeted therapies for hepatocellular carcinoma. World
J Hepatol. 2:114–126. 2010.PubMed/NCBI
|
|
22
|
Yang ZF, Ho DW, Ng MN, et al: Significance
of CD90+ cancer stem cells in human liver cancer. Cancer
Cell. 13:153–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Ma Q, Xu Q, et al: SDF-1/CXCR4
signaling induces pancreatic cancer cell invasion and
epithelial-mesenchymal transition in vitro through non-canonical
activation of Hedgehog pathway. Cancer Lett. 322:169–176. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bertran E, Caja L, Navarro E, Sancho P,
Mainez J, Murillo MM, Vinyals A, Fabra A and Fabregat I: Role of
CXCR4/SDF-1 alpha in the migratory phenotype of hepatoma cells that
have undergone epithelial-mesenchymal transition in response to the
transforming growth factor-beta. Cell Signal. 21:1595–1606. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wan L, Pantel K and Kang Y: Tumor
metastasis: moving new biological insights into the clinic. Nat
Med. 19:1450–1464. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesenchymal plasticity in cancer. Nat Med. 19:1438–1449.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chu J, Loughlin EA, Gaur NA, et al: UHRF1
phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required
for zebrafish embryogenesis. Mol Biol Cell. 23:59–70. 2012.
View Article : Google Scholar :
|
|
28
|
Sabatino L, Fucci A, Pancione M, et al:
UHRF1 coordinates peroxisome proliferator activated receptor gamma
(PPARG) epigenetic silencing and mediates colorectal cancer
progression. Oncogene. 31:5061–5072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang F, Yang YZ, Shi CZ, Zhang P, Moyer
MP, Zhang HZ, Zou Y and Qin HL: UHRF1 promotes cell growth and
metastasis through repression of p16ink4a in colorectal
cancer. Ann Surg Oncol. 19:2753–2762. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou L, Zhao X, Han Y, et al: Regulation
of UHRF1 by miR-146a/b modulates gastric cancer invasion and
metastasis. FASEB J. 27:4929–4939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li XL, Xu JH, Nie JH and Fan SJ: Exogenous
expression of UHRF1 promotes proliferation and metastasis of breast
cancer cells. Oncol Rep. 28:375–383. 2012.PubMed/NCBI
|
|
32
|
Mudbhary R, Hoshida Y, Chernyavskaya Y, et
al: UHRF1 overexpression drives DNA hypomethylation and
hepatocellular carcinoma. Cancer Cell. 25:196–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Karpf AR and Matsui S: Genetic disruption
of cytosine DNA methyltransferase enzymes induces chromosomal
instability in human cancer cells. Cancer Res. 65:8635–8639. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu S, Liu Z, Xie Z, et al: Bortezomib
induces DNA hypomethylation and silenced gene transcription by
interfering with Sp1/NF-kappaB-dependent DNA methyltransferase
activity in acute myeloid leukemia. Blood. 111:2364–2373. 2008.
View Article : Google Scholar
|
|
35
|
Batlle E, Sancho E, Franci C, Dominguez D,
Monfar M, Baulida J and Garcia De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cano A, Perez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guaita S, Puig I, Franci C, et al: Snail
induction of epithelial to mesenchymal transition in tumor cells is
accompanied by MUC1 repression and ZEB1 expression. J Biol Chem.
277:39209–39216. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Darash-Yahana M, Pikarsky E, Abramovitch
R, et al: Role of high expression levels of CXCR4 in tumor growth,
vascularization, and metastasis. FASEB J. 18:1240–1242.
2004.PubMed/NCBI
|
|
39
|
Scala S, Giuliano P, Ascierto PA, et al:
Human melanoma metastases express functional CXCR4. Clin Cancer
Res. 12:2427–2433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wald O, Shapira OM and Izhar U:
CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic
roles and therapeutic potential. Theranostics. 3:26–33. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Su L, Zhang J, Xu H, Wang Y, Chu Y, Liu R
and Xiong S: Differential expression of CXCR4 is associated with
the metastatic potential of human non-small cell lung cancer cells.
Clin Cancer Res. 11:8273–8280. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dubrovska A, Hartung A, Bouchez LC, Walker
JR, Reddy VA, Cho CY and Schultz PG: CXCR4 activation maintains a
stem cell population in tamoxifen-resistant breast cancer cells
through AhR signalling. Br J Cancer. 107:43–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gelmini S, Mangoni M, Serio M, Romagnani P
and Lazzeri E: The critical role of SDF-1/CXCR4 axis in cancer and
cancer stem cells metastasis. J Endocrinol Invest. 31:809–819.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Miki J, Furusato B, Li H, et al:
Identification of putative stem cell markers, CD133 and CXCR4, in
hTERT-immortalized primary nonmalignant and malignant tumor-derived
human prostate epithelial cell lines and in prostate cancer
specimens. Cancer Res. 67:3153–3161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kim JK, Esteve PO, Jacobsen SE and Pradhan
S: UHRF1 binds G9a and participates in p21 transcriptional
regulation in mammalian cells. Nucleic Acids Res. 37:493–505. 2009.
View Article : Google Scholar :
|
